| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/10/2016 | |
| Chairman | - | 27/10/2017 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.49Cr | |
| +0.09% | +10.80% | +58.09% | +144.25% | 1,26300Cr | |
| -0.49% | +2.00% | +45.83% | +80.79% | 66TCr | |
| -1.94% | +0.84% | +36.41% | +101.83% | 52TCr | |
| -1.54% | +0.18% | +53.06% | +66.79% | 39TCr | |
| -0.18% | +5.82% | +80.38% | +44.67% | 37TCr | |
| -1.69% | +3.17% | +32.18% | +55.35% | 31TCr | |
| -0.72% | +7.83% | +12.10% | +33.76% | 29TCr | |
| +0.40% | +5.07% | +57.67% | +75.24% | 25TCr | |
| +0.23% | +7.47% | +39.74% | +109.96% | 21TCr | |
| Average | -0.61% | +5.90% | +46.16% | +79.18% | 47.35TCr | |
| Weighted average by Cap. | -0.60% | +6.60% | +49.08% | +93.84% |
Employees
-
Sector
Pharmaceuticals
